Ceruvia Announces First Participant Dosed in BOL-148 Phase 1 Clinical Trial
17 Jan 2023 //
PR NEWSWIRE
Ceruvia Appoints Stephen Hurst and David Steinberg to its Board of Directors
02 Nov 2022 //
BIOSPACE
17 Jan 2023 //
PR NEWSWIRE
02 Nov 2022 //
BIOSPACE